Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Erlotinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,318Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data
    Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data

    17 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/daiichi-sankyo-announces-late-breaking-phase-1-dose-expansion-data-for-patritumab-deruxtecan-in-patients-with-egfr-mutated-nsclc-at-esmo-2020/?s=73

    BIOSPACE
    17 Sep 2020
    Share Share
    Zydus receives USFDA approval for Erlotinib Tablets
    Zydus receives USFDA approval for Erlotinib Tablets

    17 Apr 2020

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/news-cm/zydus-receives-usfda-approval-for-erlotinib-tablets-120041700373_1.html

    BUSINESS-STANDARD
    17 Apr 2020
    Share Share
    Cadila Healthcare gets final approval from USFDA for share price falls 3%
    Cadila Healthcare gets final approval from USFDA for share price falls 3%

    16 Apr 2020

    // MONEYCONTROL

    https://www.moneycontrol.com/news/business/stocks/cadila-healthcare-gets-final-approval-from-usfda-for-cancer-drug-but-share-price-falls-3-5159061.html

    MONEYCONTROL
    16 Apr 2020
    Share Share
    Armas Pharmaceuticals Announces Launch of Oncology Generic Erlotinib
    Armas Pharmaceuticals Announces Launch of Oncology Generic Erlotinib

    14 Nov 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/armas-pharmaceuticals-announces-launch-of-oncology-generic-erlotinib-300956958.html

    PR NEWSWIRE
    14 Nov 2019
    Share Share
    TAGRISSO, Only 1st-line Treatment for EGFR-Mutated Non-Small cell Lung Cancer
    TAGRISSO, Only 1st-line Treatment for EGFR-Mutated Non-Small cell Lung Cancer

    28 Sep 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190928005023/en

    BUSINESSWIRE
    28 Sep 2019
    Share Share
    Meet the protein responsible for nearly $100B in cancer drug deals
    Meet the protein responsible for nearly $100B in cancer drug deals

    17 Aug 2019

    // Jacob Bell BIOPHARMADIVE

    https://www.biopharmadive.com/news/meet-the-protein-responsible-for-nearly-100b-in-cancer-drug-deals/561097/

    Jacob Bell BIOPHARMADIVE
    17 Aug 2019
    Share Share